Lymphocyte activation gene 3 (LAG-3) may be an important biomarker in patients with small cell lung cancer (SCLC), according ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
The family’s long-term perspective enabled HMI’s boldest transformation, which was acquiring medical benefits administrator ...
EVM14, an off-the-shelf therapeutic mRNA cancer vaccine, is developed based on Everest Medicines’ proprietary mRNA platform. It is formulated with mRNA encoding 5 tumor-associated antigens (TAAs) and ...
EVM14 becomes Everest Medicines' internally developed therapeutic mRNA cancer vaccine to receive IND approvals from both China's National Medical Products Administration (NMPA) and the U.S. Food and ...
Google DeepMind's artificial intelligence has discovered a new way to fight cancer. The AI model, Cell2Sentence-Scale 27B, ...
Google’s Gemma-based C2S-Scale model helped Yale find a drug combo that boosts tumor antigen presentation, pointing to a new ...
China NMPA approves Everest Medicines’s IND application for tumour-associated antigen cancer vaccine EVM14: Shanghai, China Tuesday, October 14, 2025, 14:00 Hrs [IST] Everest Me ...
KDM5 inhibition/disruption selectively induces R-loop-mediated DNA damage and innate immune activation in breast cancer cells, while sparing normal cells, unveiling a tumor-specific therapeutic ...
Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback